Al Ray, MD
Urology · Roswell, GANPI 1366804544
Payments from drug & device makers
Across 33 payments — averaging $80.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$2K
- Baxter Healthcare$121
- Olympus America Inc.$110
- Sumitomo Pharma America, Inc.$54
- Coloplast$35
- Vertex$32
- plus $119 from 6 others
What the payments were for
- Travel & lodging$1,48756%
- Food & beverage$1,15744%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 20 | $2,172 |
| Baxter Healthcare | 1 | $121 |
| Olympus America Inc. | 1 | $110 |
| Sumitomo Pharma America, Inc. | 2 | $54 |
| Coloplast | 2 | $35 |
| Vertex | 1 | $32 |
| Endo USA, Inc. | 1 | $30 |
| Procept Biorobotics Corporation | 1 | $25 |
| AbbVie | 1 | $19 |
| Mimedx Group, Inc. | 1 | $18 |
| Photocure Inc | 1 | $15 |
| Myovant Sciences Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- AMS 700 CXR RTE KIT$1,449
- LITHOCLAST$129
- TISSEEL$121
- iTIND System$110
- SpaceOAR VUE System - 10mL$105
How this compares
$2,644 in reported general payments places this provider in the 35th percentile of 369 urology providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 12 | $13,299 |
| Tamsulosin Hcl | 168 | $3,052 |
| Trospium Chloride | 46 | $1,414 |
| Finasteride | 67 | $925 |
| Darifenacin ErDarifenacin Hydrobromide | 16 | $601 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 16 | $211 |
| Oxycodone Hcl | 25 | $171 |
| Ciprofloxacin Hcl | 20 | $151 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 11 | $70 |
Paid to pharmacies, not to this prescriber.
Other urology in Roswell
- Vahan KassabianRoswell$3M
- Lewis KritemanRoswell$864K
- Scott MillerRoswell$85K
- Akash KapadiaRoswell$79K
- Herman BaggaRoswell$67K
- Sophia GoodridgeRoswell$18K
- Daniel BelewRoswell$16K
- Viraj MasterAtlanta$2M
- Vikram NarayanAtlanta$1.1M
- Daniel CanterDecatur$611K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.